ArticleSensors (Basel, Switzerland)2022
Automatic Detection of Liver Cancer Using Hybrid Pre-Trained Models.
Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 36 citations in OpenAlex.
- Artificial intelligence and oral microbiome: Reshaping the diagnostic and therapeutic paradigm of OSCC.Clinical and translational medicine · 2026Review
- AI for interpreting screening mammograms: implications for missed cancer in double reading practices and challenging-to-locate lesions.Scientific reports · 2024Article
- Article
- Using hybrid pre-trained models for breast cancer detection.PloS one · 2024Article
- Mixed reality navigation training system for liver surgery based on a high-definition human cross-sectional anatomy data set.Cancer medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
Abstract
Liver cancer is a life-threatening illness and one of the fastest-growing cancer types in the world. Consequently, the early detection of liver cancer leads to lower mortality rates. This work aims to build a model that will help clinicians determine the type of tumor when it occurs within the liver region by analyzing images of tissue taken from a biopsy of this tumor. Working within this stage requires effort, time, and accumulated experience that must be possessed by a tissue expert to determine whether this tumor is malignant and needs treatment. Thus, a histology expert can make use of this model to obtain an initial diagnosis. This study aims to propose a deep learning model using convolutional neural networks (CNNs), which are able to transfer knowledge from pre-trained global models and decant this knowledge into a single model to help diagnose liver tumors from CT scans. Thus, we obtained a hybrid model capable of detecting CT images of a biopsy of a liver tumor. The best results that we obtained within this research reached an accuracy of 0.995, a precision value of 0.864, and a recall value of 0.979, which are higher than those obtained using other models. It is worth noting that this model was tested on a limited set of data and gave good detection results. This model can be used as an aid to support the decisions of specialists in this field and save their efforts. In addition, it saves the effort and time incurred by the treatment of this type of cancer by specialists, especially during periodic examination campaigns every year.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.